Suicidal overdose of dolutegravir: A case report
Dolutegravir (DTG) is the most recently introduced integrase inhibitor for the treatment of HIV infection and is preferred for its superior tolerability and efficacy in both new and pre-treated patients, and infrequent drug interactions. Since January 2017, Botswana has adopted a ‘treat-all’ approac...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AOSIS
2018-06-01
|
| Sarja: | Southern African Journal of HIV Medicine |
| Aiheet: | |
| Linkit: | https://sajhivmed.org.za/index.php/hivmed/article/view/799 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|